FASCIOLIASIS

Clinical trials for FASCIOLIASIS explained in plain language.

Never miss a new study

Get alerted when new FASCIOLIASIS trials appear

Sign up with your email to follow new studies for FASCIOLIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Breakthrough liver fluke drug shows promise in largest safety trial yet

⭐️ CURE ⭐️ Completed

This study tested the safety and effectiveness of EGATEN (triclabendazole) in 301 people aged 6 and older with fascioliasis, a parasitic liver infection. Participants received two doses of the drug 12 hours apart and were monitored for 90 days. The goal was to see if the treatmen…

Matched conditions: FASCIOLIASIS

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: ⭐️ CURE ⭐️

Last updated May 20, 2026 11:53 UTC

FASCIOLIASIS

Get alerted when new FASCIOLIASIS trials appear

Breakthrough liver fluke drug shows promise in largest safety trial yet